Alexion, Pfizer sign $1 billion accord for genomic medicines
HQ Team July 29, 2023: Alexion, AstraZeneca Rare Disease, an arm of AstraZeneca group, has signed a $1 billion pact with Pfizer for.
Drugs
Health
Pharma